Researchers determined baseline BMD T-score cutoffs for achieving a T-score of higher than –2.5 with abaloparatide and teriparatide. Anabolic therapies may be better for adults needing a larger ...

Dan Dischner; Vice President - Corporate Communications; Amphastar Pharmaceuticals Inc. William Peters; Chief Financial Officer, Executive Vice President - Finance, ...

Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key business ...

In osteoporosis, bones lose minerals more than the body can replace them with new ones, leaving them thinner and more brittle. Various factors can increase your risk of developing osteoporosis, with ...

Operator: Greetings and welcome to the Amphastar Pharmaceuticals First Quarter Earnings Call. At this time, all participants ...

Entera continued to generate intrinsic value with progress across our programs while significantly extending our cash runway into late 2026 via direct investment from marquis investors and our ...

At approximately 3 hours, the half-life of PTH(1-84) is longer than that of teriparatide, but still inadequate to effectively lower urine calcium losses. Like PTH(1-34), recombinant PTH(1-84 ...

Total hip BMD increases were associated with reduced risk for vertebral and all clinical fractures across active control or sequential therapy trials.

EB613 comprises the first 34 N-terminal amino acid sequence of the human parathyroid hormone, PTH(1-34) or teriparatide, which is a validated standard of care and only available as a daily ...

Learn more about whether BioCryst Pharmaceuticals, Inc. or Halozyme Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and ...